253 related articles for article (PubMed ID: 34452525)
21. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
22. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction.
Tan CW; Sam IC; Lee VS; Wong HV; Chan YF
Virology; 2017 Jan; 501():79-87. PubMed ID: 27875780
[TBL] [Abstract][Full Text] [Related]
23. Establishment of Asia-Pacific Network for Enterovirus Surveillance.
Chiu ML; Luo ST; Chen YY; Chung WY; Duong V; Dussart P; Chan YF; Perera D; Ooi MH; Thao NTT; Truong HK; Lee MS
Vaccine; 2020 Jan; 38(1):1-9. PubMed ID: 31679864
[TBL] [Abstract][Full Text] [Related]
24. Discovery of Enterovirus A71-like nonstructural genomes in recent circulating viruses of the Enterovirus A species.
Lee KM; Gong YN; Hsieh TH; Woodman A; Dekker NH; Cameron CE; Shih SR
Emerg Microbes Infect; 2018 Jun; 7(1):111. PubMed ID: 29930332
[TBL] [Abstract][Full Text] [Related]
25. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
26. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
27. Interplays between Enterovirus A71 and the innate immune system.
Chen KR; Ling P
J Biomed Sci; 2019 Dec; 26(1):95. PubMed ID: 31787104
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines.
Apostol LN; Shimizu H; Suzuki A; Umami RN; Jiao MMA; Tandoc A; Saito M; Lupisan S; Oshitani H
BMC Infect Dis; 2019 May; 19(1):370. PubMed ID: 31046684
[TBL] [Abstract][Full Text] [Related]
29. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
30. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
31. A Mouse Model for Infection with Enterovirus A71 in Small Extracellular Vesicles.
Gu J; Wu J; Cao Y; Zou X; Jia X; Yin Y; Shen L; Fang D; Mao L
mSphere; 2020 Jul; 5(4):. PubMed ID: 32611697
[TBL] [Abstract][Full Text] [Related]
32. dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication.
Chang YH; Lau KS; Kuo RL; Horng JT
Front Cell Infect Microbiol; 2017; 7():284. PubMed ID: 28702377
[TBL] [Abstract][Full Text] [Related]
33. Hsp27 Responds to and Facilitates Enterovirus A71 Replication by Enhancing Viral Internal Ribosome Entry Site-Mediated Translation.
Dan X; Wan Q; Yi L; Lu J; Jiao Y; Li H; Song D; Chen Y; Xu H; He ML
J Virol; 2019 May; 93(9):. PubMed ID: 30814282
[TBL] [Abstract][Full Text] [Related]
34. Genetic Characterization of Enterovirus A71 Circulating in Africa.
Fernandez-Garcia MD; Volle R; Joffret ML; Sadeuh-Mba SA; Gouandjika-Vasilache I; Kebe O; Wiley MR; Majumdar M; Simon-Loriere E; Sakuntabhai A; Palacios G; Martin J; Delpeyroux F; Ndiaye K; Bessaud M
Emerg Infect Dis; 2018 Apr; 24(4):754-757. PubMed ID: 29553325
[TBL] [Abstract][Full Text] [Related]
35. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility and cytokine responses of human neuronal cells to multiple circulating EV-A71 genotypes in India.
Mohanty MC; Varose SY; Saxena VK
Sci Rep; 2021 Sep; 11(1):17751. PubMed ID: 34493781
[TBL] [Abstract][Full Text] [Related]
37. Mouse Scarb2 Modulates EV-A71 Pathogenicity in Neonatal Mice.
Miwatashi W; Ishida M; Takashino A; Kobayashi K; Yamaguchi M; Shitara H; Koike S
J Virol; 2022 Aug; 96(15):e0056122. PubMed ID: 35867561
[TBL] [Abstract][Full Text] [Related]
38. Seroepidemiological and phylogenetic characterization of neurotropic enteroviruses in Ireland, 2005-2014.
Guerra JA; Waters A; Kelly A; Morley U; O'Reilly P; O'Kelly E; Dean J; Cunney R; O'Lorcain P; Cotter S; Connell J; O'Gorman J; Hall WW; Carr M; De Gascun CF
J Med Virol; 2017 Sep; 89(9):1550-1558. PubMed ID: 28071799
[TBL] [Abstract][Full Text] [Related]
39. Genetic evolution of Human Enterovirus A71 subgenotype C4 in Shenzhen, China, 1998-2013.
He Y; Zou L; Chong MKC; Men R; Xu W; Yang H; Yao X; Chen L; Xian H; Zhang H; Luo M; Cheng J; Ma H; Feng Q; Huang Y; Wang Y; Yeoh EK; Zee BC; Zhou Y; He ML; Wang MH
J Infect; 2016 Jun; 72(6):731-737. PubMed ID: 27038503
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants and heterogeneity underlying host response to EV-A71 infection at single-cell resolution.
Kuo RL; Chen YT; Li HA; Wu CC; Chiang HC; Lin JY; Huang HI; Shih SR; Chin-Ming Tan B
RNA Biol; 2021 May; 18(5):796-808. PubMed ID: 33406999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
